Stay updated on Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-28T15:32:29.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says that “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-21T20:40:29.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer shows revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-14T20:39:24.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer revision identifier advances from v3.7.0 to v3.7.1 on the ClinicalTrials.gov 403 error page.
    Difference
    0.2%
    Check dated 2026-10-07T20:54:45.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error with the basic HTML header and a Home link, replacing the previous study-record content; several navigation and document-related sections are removed in this view.
    Difference
    20%
    Check dated 2026-09-23T21:38:54.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    A new revision tag v3.7.0 has been added, replacing the previous v3.6.6 to record an updated page revision.
    Difference
    0.0%
    Check dated 2026-09-16T22:24:28.000Z thumbnail image

Stay in the know with updates to Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page.